Intermolecular (IMI) Tops Q3 EPS by 2c

Intermolecular (NASDAQ: IMI) reported Q3 EPS of ($0.07), $0.02 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $10.9 million versus the consensus estimate of $10.6 million.

Intermolecular sees Q4 2014 EPS of ($0.12)-($0.1), versus the consensus of ($0.08). Intermolecular sees Q4 2014 revenue of $10-11 million, versus the consensus of $11.2 million.

For earnings history and earnings-related data on Intermolecular (IMI) click here.

You May Also Be Interested In

• Gilead Sciences (GILD) Misses Q1 EPS by 288c
• USCB Financial Holdings, Inc. (USCB) Tops Q1 EPS by 2c
• L3Harris Technologies (LHX) Tops Q1 EPS by 15c; raises guidance